0      0


153 - Urinary Incontinence A - Z


‐ Nov 1, 2014 1:45pm

Urinary incontinence and overactive bladder are growing healthcare problems that are often unreported due to embarrassment and the myth that urinary in continence is a normal part of aging and that there is nothing besides surgery that can be done to treat it. During this session, we discuss the different types of incontinence, patient evaluation, and treatment options available. Urinary incontinence is not life threatening, it is life-style threatening.

Contact hours available until 11/3/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners and Authors Conflict of Interest Disclosure:
Planning Committee Disclosures:

Gina M. Powley, MSN, ANP-BC
Consultant: Ferring Pharmaceuticals, Astellas/Medivation

Leanne Schimke, MSN, CRNP-C, CUNP
Speaker's Bureau: Bayer-Xofigo, Amgen-Denosumab

There are no other disclosures to declare.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.

Objectives:

• Discuss urinary incontinence and its impact on QOL
• Discuss the assessment of the patient with UI.
• Integrate assessment and treatment options for the patient with UI.


Speaker(s):

You must be logged in and own this session in order to post comments.